Two "key" genes have been identified by scientists linking the painful condition and the bone disease osteoporosis.

Two “key” genes could help doctors identify arthritis earlier in patients and help those suffering from the bone disease ...

Key lessons include the need for improved risk stratification tools and better understanding ... at all the people who get rheumatoid arthritis, there’s probably no way those could have the same exact ...

The risk factors of rheumatoid arthritis (RA) include those you might expect, such as age, gender, and genes. But lifestyle factors also influence your chances of developing RA, including smoking and ...

I also have an arsenal of tools that I use to help alleviate and control my RA foot pain. Proper supportive shoes and ...

Rheumatoid arthritis (RA) causes your body to mistakenly ... Early diagnosis and treatment may help slow the progression of RA. Disease-modifying medications, medications to relieve your symptoms ...

An international quality improvement initiative focused on supporting rheumatoid arthritis (RA) patients to reach their full ...

The therapeutic window of opportunity in rheumatoid arthritis (RA) is often referred to. However, some have questioned whether such a period, in which the disease is more susceptible to ...

The nerve doesn’t branch out in the upper arm but passes through the elbow to help provide movement and sensation in the ... an underactive thyroid gland, and rheumatoid arthritis. Mechanical problems ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...

They also experienced significant improvement in knee pain and function FRIDAY, Nov. 1, 2024 (HealthDay News) -- The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a ...

The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found. People who received weekly injections of semaglutide -- the active agent in the diabetes ...